ArticleCommunications medicine2023
Smartphone-based point-of-care anemia screening in rural Bihar in India.
Article in Communications medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Evaluating a biochemical TB medication adherence test: Insights from image-based reporting through a patient companion app.PLOS global public health · 2026Article
- Point of care devices in primary care setting in india: A scoping review.BMC primary care · 2025Article
- Potential of the World Health Organization's Skin NTDs App to Support and Improve the Detection of Skin-Related Neglected Tropical Diseases: Protocol for a Performance Evaluation and Feasibility Study in Senegal.JMIR research protocols · 2025Article
- Article
- Real-world implementation of a noninvasive, AI-augmented, anemia-screening smartphone app and personalization for hemoglobin level self-monitoring.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Article
- Radiomic identification of anemia features in monochromatic conjunctiva photographs in school-age children.Biophotonics discovery · 2025Article
- Non - Invasive, smartphone image-based screening for sickle cell disease at the point-of-need.Heliyon · 2025Article
- Enhancing anemia diagnostics and accessibility in India: a policy recommendation for effective anemia management.Frontiers in health services · 2025Article
- Article
- Telemedicine in nephrology: future perspective and solutions.Clinical kidney journal · 2024Article
- Explainable AI decision support improves accuracy during telehealth strep throat screening.Communications medicine · 2024Article
- Article
- Relationship between adolescent anemia and school attendance observed during a nationally representative survey in India.Communications medicine · 2024Article
- Prediction of anemia in real-time using a smartphone camera processing conjunctival images.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe high prevalence of anemia in resource-constrained settings calls for easy-to-use, inexpensive screening tools. The Sanguina Smartphone App, an innovative tool for non-invasive hemoglobin estimation via color-sensitive, algorithm-based analysis of fingernail bed images, was validated in the United States. This study evaluates the performance of the App in a population with different socio-economic, ethnic, demographic and cultural composition in rural Bihar, India.
methodsFor 272 mainly adult patients of a private health centre, hemoglobin measurement with the App is compared with the gold standard laboratory blood analysis. For a second sample of 179 children attending pre-schools, hemoglobin measurement with the App is compared to the results of the HemoCue Hb 301, a point-of-care device using a small blood sample, serving as the reference standard for field-based settings.
resultsThe App reaches ±4.43 g/dl accuracy and 0.38 g/dl bias of comparator values in the clinic-based sample, and ±3.54 g/dl and 1.30 g/dl, respectively in the pre-school sample. After retraining the algorithm with the collected data, the validity of the upgraded version is retested showing an improved performance (accuracy of ±2.25 g/dl, bias of 0.25 g/dl), corresponding to the results of the original validation study from the United States.
conclusionsThe initial version of the App does not achieve the accuracy needed for diagnosis or screening. After retraining the algorithm, it achieves an accuracy sufficient for screening. The improved version with the potential for further adaptions is a promising easy-to-use, inexpensive screening tool for anemia in resource-constrained point-of-care settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.